Replies to post #35250 on Biotech Values

[masterlongevity]

I would guess Macugen sales were hurt the most. A lot of retinal specialists are still using visudyne in combo with avastin or Lucentis. Lucentis uses the same MOA as Macugen but works 100x better. I think visudyne might stick around for a while but macugen is over.